Influence of capsular pseudoexfoliation syndrome on hearing loss
DOI:
https://doi.org/10.31053/1853.0605.v77.n2.27861Keywords:
exfoliation syndrome, hearing loss sensorineural, audiometryAbstract
Introduction: Pseudoexfoliation Syndrome (PEX) is a genetic-inherited disorder, consisting of the deposition of elastin microfibers in intra and extraocular tissue. PEX is one of the most common identifiable secondary causes of glaucoma. Several studies have associated PEX with systemic conditions and the finding of fibrillar material in the structures of the inner ear, similar to that of pseudoexfoliation detected in the eye, has been described.
Objective: to compare audiometric levels in patients with and without ocular PEX. Materials and Methods: Retrospective case-control study. 48 medical records of patients who attended the ophthalmology service of the Private Hospital of Córdoba were selected between January 2015 and December 2017, between 59 and 75 years. They were divided into groups: controls (n = 22): without PEX and cases (n = 26): with PEX. The medical records of patients who underwent ophthalmological and audiometric studies were analyzed. For the statistical analysis, the Student's T test was used for independent and paired samples; in all cases a level of significance ≤ 0.05 was considered.
Results: The percentage of hearing loss was 56.8% in the control group and 82.7% in the PEX group. The percentage disability in the group with PEX was greater in monaural (p = 0.0008) and biaural (p = 0.0307) hearing compared to patients without PEX.
Conclusion: Patients with ocular PEX showed a higher percentage of hearing loss, compared to those patients without ophthalmic evidence of PEX.
Downloads
References
2. Schlotzer-Schrehardt U. Genetics and genomics of pseudoexfoliation syndrome/ glaucoma. Middle East Afr J Ophthalmol 2011; 18 (1): 30-6.
3. Shaban RI, Asfour WM. Ocular pseudoexfoliation associated with hearing loss. Saudi Med J. 2004; 25(9):1254-1257
4. George A. Cioffi y col. Glaucoma seccion 10 (2008-2009) America Academy of ophthalmology edicion Elsevier pag 104,105.
5. Andrikopoulos GK, Alexopoulos DK, Gartaganis SP. Pseudoexfoliation syndrome and cardiovascular diseases. World J Cardiol. 2014 Aug 26;6(8):847-54.
6. Schlotzer-Schrehardt U, Naumann GO. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 2006; 141 (5): 921-37.
7. Demir N, Ulus T, Yucel OE, Kumral ET, Singar E, Tanboga HI. Assessment of myocardial ischaemia using tissue Doppler imaging in pseudoexfoliation syndrome. Eye (Lond). 2011 Sep;25(9):1177-80.
8. Tsuprun V, Santi P. Ultrastructural organization of proteoglycans and fibrillar matrix of the tectotial membrane. Hear Res. 1986; 110 (1-2): 107-118
9. Vafa, S; Reza, S; Negar, H; Elznar J. Sensory-neural hearing loss in pseudoexfoliationSíndrome. Int J Ophthalmolvol 5. No 3. Jun 18, 2012.
10. Strenzke, D. Pauli-Magnus, A. Meyer, A. Brandt, H. Maier, and T. Moser, Update on physiology and pathophysiology of the inner ear: pathomechanisms of sensorineural hearing loss, HNO, vol. 56, no. 1, pp. 27–36, 2008.
11. Lim DJ. Functional Structure of the organ of corti: a review. Hear Res 1986;22(1-3):117-146.
12. Louw C, Swanepoel W, Eikelboom RH, Hugo J. Prevalence of hearing loss at primary health care clinics in South Africa. Afr Health Sci. 2018 Jun;18(2):313-320.
13. American National Standards Institute (ANSI) Specification of Hearing Aid characteristics, Part 6: Recommended Measurements, Specifications, and Tolerances. ANSI S3.22. New York, NY: ANSI; 2003.
14. Tabla de Pérdidas Auditivas basada en umbrales Audiométricos con corrección para normas ISO. American Medical Asociation - Council of Physical Therapy and Rehabilitation. http://www.audita.com.ar/info/tablaama84.html. Fecha de búsqueda: 19.12.2019.
15.Hayrehss, Podhajsky P, Zimmerman B. Ocular and optic nerve head ischemic disorders and hearing loss. Am J Ophthalmol 1999.128: 606-611.
16. Kremmer S, Kreuzfelder E, Bschor E, Jahke K, Selbach JM, Seidahmadi S. Coincidence of normal tension glaucoma, progressive sensorineural hearing loss, and elevated antiphosphatidylserine antibodies.Br J Ophthalmol 2004; 88: 1259-1262.
17. Aydogan, Ozkan B, Yuksel N, Keskin G, Altintas O, Karabas VL, Caglar Y, Alamac A. Homocysteinelevelsin plasma and sensorineural hearing loss in patients with pseudoexfoliation syndrome. Eur J Ophthalmol 2006; 16: 542-547.
18. Singham NV, Zahari M, Peyman M, Prepageran N, Subrayan V. Association between Ocular Pseudoexfoliation and Sensorineural Hearing Loss. J Ophthalmol. 2014; 2014:825936. doi: 10.1155/2014/825936. Epub 2014 Apr 17. PubMed PMID:
24864196; PubMed Central PMCID: PMC4016926.
19. Yazdani S, Tousi A, Pakravan M, Faghihi A, “Sen-sorineural Hearing Loss in Pseudoexfoliation Syndrome,”Oph-thalmology, vol. 115, no. 3, pp. 425–429, 2008.
20. Zojaji R, Alesheykh A, Sedaghat MR, Navia K, Mazloom Farsi Baf M, Khaki M,Raouf A. Pseudoexfoliation syndrome and sensorineural hearing loss. Iran JOtorhinolaryngol. 2011 Fall;23(65):149-58.
21. Samarai V, Samarei R, Haghighi N, Jalili E. Sensory-neural hearing loss in pseudoexfoliation syndrome. Int J Ophthalmol. 2012;5(3):393-6.
Published
How to Cite
Issue
Section
License
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).